Atlas Trials

A Study on Nausea and Vomiting Caused by T-DXd in Breast Cancer Patients

Clinical trial NCT07254416 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07254416
Sponsor
Tianjin Medical University Cancer Institute and Hospital
Status
NOT_YET_RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Breast Cancer Patients Treated With T-DXd
Start date
2025-12-15
Primary completion
2026-12-31
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.